'Incentives for American Medical Innovation: Protecting America's Greatest Innovators' Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation

Briefing is the final in a three-part series on "Achieving Recovery Through Discovery"

WASHINGTON, Sept. 29 /PRNewswire-USNewswire/ --

    WHAT:  The Council for American Medical Innovation will host a breakfast
           briefing on Capitol Hill titled "Incentives for American Medical
           Innovation - Protecting America's Greatest Innovators."  Political
           leaders, pharmaceutical industry and health policy experts will
           explore important changes needed in public policy to support
           America's pipeline of innovative treatments.  The Council believes
           fostering a legal and regulatory environment that protects
           intellectual property is critical to maintaining America's
           leadership in medical innovation and ensuring a continued stream
           of new, life-saving medical treatments.

           This is the final briefing in a three-part series that has
           examined the role of public policy in promoting medical innovation
           to help our nation recover from health and economic crises.  For
           details on all of the briefings, visit:
           www.americanmedicalinnovation.org.

    (Logo: http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO )

    WHO:   Remarks by:
           -----------

           - Marc Boutin, J.D., Executive Director and Chief Operating
             Officer of the National Health Council
           - The Honorable Richard Gephardt, Former Democratic Leader of the
             U.S. House of Representatives, Chairman of the Council for
             American Medical Innovation
           - John Holdren, Ph.D., Director of the White House Office of
             Science and Technology Policy (invited)
           - Debra Lappin, President of the Council for American Medical
             Innovation
           - The Honorable Edward Markey, U.S. Representative (D-MA) (invited)
           - Greg Simon, Senior Vice President of Worldwide Policy, Pfizer
             Inc.
           - Kelly Slone, Director of Federal Life Science Policy, National
             Venture Capital Association

           *Richard Gephardt and other panelists will be available for media
           interviews between 9:30 and 10 a.m.  Please contact Laura Lowery,
           206-799-5604 to secure an interview.

    WHERE: Rayburn House Office Building, Room B338

    WHEN:  Monday, October 5, 2009
           8:30 - 9:30 a.m.
           RSVP: http://www.regonline.com/recoverythroughdiscovery

About the Council for American Medical Innovation

The United States faces serious challenges to maintaining its leadership position in innovation. The Council for American Medical Innovation is bringing together leaders in research, medicine, public health, academia, education, labor, and business, who are working in partnership toward a national policy agenda aimed at preserving U.S. leadership in medical innovation. American medical innovators create millions of high-paying jobs, and their discoveries are integral in the fight to cure cancer and other illnesses. The Council for American Medical Innovation views leadership in medical innovation as a key part of America's economic recovery, future prosperity and health.

For more information on the Council for American Medical Innovation, visit www.americanmedicalinnovation.org.

    Laura Lowery
    206-799-5604
    laura.lowery@americanmedicalinnovation.org

SOURCE Council for American Medical Innovation

RELATED LINKS
http://www.americanmedicalinnovation.org